Bausch Health Cos Pre-Tax Income 2010-2024 | BHC
Bausch Health Cos pre-tax income from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
Bausch Health Cos Annual Pre-Tax Income
(Millions of US $) |
| 2023 |
$-390 |
| 2022 |
$-129 |
| 2021 |
$-1,024 |
| 2020 |
$-934 |
| 2019 |
$-1,837 |
| 2018 |
$-4,154 |
| 2017 |
$-1,741 |
| 2016 |
$-2,435 |
| 2015 |
$-155 |
| 2014 |
$1,054 |
| 2013 |
$-1,314 |
| 2012 |
$-394 |
| 2011 |
$-18 |
| 2010 |
$-236 |
| 2009 |
$175 |
Bausch Health Cos Quarterly Pre-Tax Income
(Millions of US $) |
| 2024-06-30 |
$48 |
| 2024-03-31 |
$-69 |
| 2023-12-31 |
$-7 |
| 2023-09-30 |
$-326 |
| 2023-06-30 |
$79 |
| 2023-03-31 |
$-136 |
| 2022-12-31 |
$-357 |
| 2022-09-30 |
$439 |
| 2022-06-30 |
$-129 |
| 2022-03-31 |
$-82 |
| 2021-12-31 |
$21 |
| 2021-09-30 |
$216 |
| 2021-06-30 |
$-670 |
| 2021-03-31 |
$-591 |
| 2020-12-31 |
$-394 |
| 2020-09-30 |
$75 |
| 2020-06-30 |
$-437 |
| 2020-03-31 |
$-178 |
| 2019-12-31 |
$-1,470 |
| 2019-09-30 |
$-66 |
| 2019-06-30 |
$-179 |
| 2019-03-31 |
$-122 |
| 2018-12-31 |
$-426 |
| 2018-09-30 |
$-300 |
| 2018-06-30 |
$-734 |
| 2018-03-31 |
$-2,694 |
| 2017-12-31 |
$-804 |
| 2017-09-30 |
$-400 |
| 2017-06-30 |
$-242 |
| 2017-03-31 |
$-295 |
| 2016-12-31 |
$-360 |
| 2016-09-30 |
$-1,332 |
| 2016-06-30 |
$-377 |
| 2016-03-31 |
$-366 |
| 2015-12-31 |
$-268 |
| 2015-09-30 |
$-6 |
| 2015-06-30 |
$-65 |
| 2015-03-31 |
$183 |
| 2014-12-31 |
$552 |
| 2014-09-30 |
$377 |
| 2014-06-30 |
$121 |
| 2014-03-31 |
$5 |
| 2013-12-31 |
$-78 |
| 2013-09-30 |
$-1,141 |
| 2013-06-30 |
$-40 |
| 2013-03-31 |
$-55 |
| 2012-12-31 |
$-275 |
| 2012-09-30 |
$-89 |
| 2012-06-30 |
$-17 |
| 2012-03-31 |
$-13 |
| 2011-12-31 |
$-77 |
| 2011-09-30 |
$12 |
| 2011-06-30 |
$44 |
| 2011-03-31 |
$3 |
| 2010-12-31 |
$-134 |
| 2010-09-30 |
$-148 |
| 2010-06-30 |
$39 |
| 2010-03-31 |
$6 |
| 2009-12-31 |
$48 |
| 2009-09-30 |
$48 |
| 2009-06-30 |
$28 |
| 2009-03-31 |
$51 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.956B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
